Shell Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Shell Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,170	Closed	-$220K	–	1479
2020 Q3	$220K	Hold	4,170	–	–	0.01%	1019
2020 Q2	$256K	Sell	4,170 -85	-2%	-$4.92K	0.01%	950
2020 Q1	$241K	Sell	4,255 -65	-2%	-$3.7K	0.01%	950
2019 Q4	$246K	Sell	4,320 -131	-3%	-$6.95K	0.01%	1097
2019 Q3	$238K	Sell	4,451 -38	-0.8%	-$2.21K	0.01%	1100
2019 Q2	$268K	Sell	4,489 -3,572	-44%	-$225K	0.01%	1071
2019 Q1	$502K	Hold	8,061	–	–	0.01%	908
2018 Q4	$488K	Sell	8,061 -700	-8%	-$41.8K	0.01%	852
2018 Q3	$512K	Buy	+8,761	New	+$447K	0.01%	950

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Shell Asset Management's BSTC Position: Q4 2020 in Review

Shell Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 4,170 shares — an estimated $220K sold.

Shell Asset Management first reported a position in BSTC in Q3 2018 and held it in 9 quarters. The position peaked at $512K in Q3 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Shell Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Shell Asset Management sold 4,170 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $220K.
Shell Asset Management first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 9 quarters.
Shell Asset Management's BioSpecifics Technologies Corp. position peaked at $512K in Q3 2018.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Shell Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.